stockrowBeOne Medicines Ltd. - Sponsored ADR
BeOne Medicines Ltd. - Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $5.3 billion, up 40.2% from fiscal 2024.
- Revenue
- +33.8%
- EPS
- +143.7%
- Free cash flow
- +33.6%
- Total debt
- +491.3%
Quarter to September 2026, against a year earlier
Follow ONC
Alert me
BeOne Medicines Ltd. - Sponsored ADR (ONC) Gross margin
BeOne Medicines Ltd. - Sponsored ADR's gross margin over the twelve months to 30 September 2026 was 89.4%, up 1.9 percentage points from fiscal 2025 (87.5%). Over the past ten years it has ranged from 77.1% (fiscal 2020) to 100.0% (fiscal 2016); the current reading is higher than 73% of that period. That is above the Biotechnology industry median of 65.2% and above the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 87.5% | 3.08 |
| FY2024 | 84.4% | (0.14) |
| FY2023 | 84.6% | 4.78 |
| FY2022 | 79.8% | (6.21) |
| FY2021 | 86.0% | 8.86 |
| FY2020 | 77.1% | (6.26) |
| FY2019 | 83.4% | (2.14) |
| FY2018 | 85.5% | (12.39) |
| FY2017 | 97.9% | (2.09) |
| FY2016 | 100.0% | 0.00 |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 88.5% | (1.24) |
| Jun 2026 | 89.8% | 0.81 |
| Mar 2026 | 89.0% | (1.54) |
| Dec 2025 | 90.5% | 4.40 |
| 40 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| RPRX Royalty Pharma PLC compare | 100.0% |
| RVMD Revolution Medicines, Inc. compare | 95.6% |
| GMAB Genmab A/S Sponsored ADR compare | 93.0% |
| INCY Incyte Corporation compare | 92.7% |
| ARGX argenex SE compare | 90.2% |
| ONC BeOne Medicines Ltd. - Sponsored ADR | 89.4% |
| INSM Insmed, Inc. compare | 84.4% |
| ROIV Roivant Sciences Ltd. compare | 81.2% |
| BNTX BioNTech SE Sponsored ADR compare | 74.6% |
| Biotechnology industry median | 65.2% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on ONC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement